Literature DB >> 7164110

Catecholamines in honey bee (Apis mellifera L.) and various vespid (Hymenoptera) venoms.

M D Owen, A R Bridges.   

Abstract

Liquid chromatography with electrochemical detection was used to separate, identify and quantitate the levels of dopamine (DA) and noradrenaline (NA) present in the venoms of honey bees of known ages and of DA and 5-hydroxytryptamine (5-HT) in various species of vespid wasps. Fluorescence histochemistry corroborated the presence of amines in honey bee venom glands and reservoirs and supported the quantitative results. The results show: (i) There is an age dependent variation in DA and NA levels in honey bee venom and there may be a similar variation in DA and 5-HT in the venom of queen Dolichovespula arenaria. (ii) There appears to be a seasonal variation in the quantities of DA and NA present in honey bee venom. Such a seasonal variation may be one of the factors involved in the variation in the levels of amine components present in the various vespid wasp venom samples. (iii) 5-HT is present in much greater quantities than DA in vespid venoms. Low levels of NA and DOPA are present in vespid venoms.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164110     DOI: 10.1016/0041-0101(82)90110-6

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  3 in total

1.  [Wasp-sting-induced pheochromozytoma crisis with stress-related cardiomyopathy (Takotsubo)].

Authors:  S Hausen; A Treusch; C Hermes; P Boekstegers
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-11-06       Impact factor: 0.840

2.  Changes in brain amine levels associated with the morphological and behavioural development of the worker honeybee.

Authors:  D J Taylor; G E Robinson; B J Logan; R Laverty; A R Mercer
Journal:  J Comp Physiol A       Date:  1992-07       Impact factor: 1.836

3.  Identification and quantification of honeybee venom constituents by multiplatform metabolomics.

Authors:  Agnieszka Klupczynska; Szymon Plewa; Paweł Dereziński; Timothy J Garrett; Vanessa Y Rubio; Zenon J Kokot; Jan Matysiak
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.